Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Lancing Devices And Equipment Market Set To Climb From $3.52 Billion In 2026 To $4.98 Billion By 2030#_x000D_
The lancing devices and equipment market size has demonstrated significant expansion in recent years. This market is set to expand from $3.25 billion in 2025 to $3.52 billion in 2026, registering a compound annual growth rate (CAGR) of 8.4%. The upward trend observed in the past can be attributed to the escalating occurrence of diabetes, the broadening implementation of self-monitoring blood glucose practices, improved access to disposable medical devices, advancements in lancet safety designs, and the growth of point-of-care diagnostics._x000D_
_x000D_
The lancing devices and equipment market is projected to experience robust expansion in the coming years. It is forecast to increase to $4.98 billion in 2030, achieving a compound annual growth rate (CAGR) of 9.1%. This anticipated growth during the forecast period stems from factors such as the escalating demand for home diagnostics solutions, an intensified focus on patient comfort and adherence, the expansion of chronic disease monitoring initiatives, the rising integration of minimally invasive sampling devices, and increased capital directed towards personal healthcare technologies. Prominent trends expected in this period encompass the wider adoption of single-use safety lancets, an increasing preference for sampling devices designed to minimize pain, the growing use of glucose monitoring at home, developments in adjustable depth lancing technologies, and a strengthened emphasis on infection prevention._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Lancing Devices And Equipment Market Development Factors: What’s Supporting Demand?#_x000D_
The increasing incidence of diabetes is propelling the expansion of the lancing devices and equipment market. Diabetes, a persistent metabolic condition marked by high blood sugar levels, necessitates frequent surveillance for effective management and to avert issues like neuropathy, cardiovascular disease, and kidney damage. This growing occurrence of diabetes stems from rising obesity rates, which induce insulin resistance and metabolic irregularities, ultimately contributing to the disease’s onset. The expanding prevalence of diabetes, in turn, bolsters the lancing devices and equipment sector by heightening the need for reliable, precise, and user-friendly blood sampling instruments, facilitating regular glucose checks both at home and in healthcare environments. For example, reports from The Guardian, a United Kingdom based news organization, indicated that in February 2025, the United Kingdom saw 12.2 million individuals impacted by diabetes or non-diabetic hyperglycaemia. This figure comprised 4.6 million with diagnosed diabetes, 1.3 million with undiagnosed diabetes, and 6.3 million with non-diabetic hyperglycaemia, marking an increase from approximately 12.1 million cases observed between 2023 and 2024. Consequently, the increasing prevalence of diabetes is a key driver for the expansion of the lancing devices and equipment market._x000D_
_x000D_
#Lancing Devices And Equipment Market Segmentation: How Does The Market Break Down By Category?#_x000D_
The lancing devices and equipment market covered in this report is segmented – _x000D_
_x000D_
1) By Usage Mode: Reusable, Disposable _x000D_
2) By Product: Safety Lancets, Standard Lancets _x000D_
3) By Penetration Depth: 0.8mm-1mm, 1.1mm- 1.5mm, 1.6mm-2.0mm, Other Penetration Depths_x000D_
4) By End User: Hospitals and Clinics, Homecare and Home Diagnostics, Diagnostic Centres and Medical Institutions, Research and Academic Laboratories, Other End User_x000D_
_x000D_
Subsegments:_x000D_
1) By Reusable: Manual Reusable Lancets, Automated Reusable Lancets _x000D_
2) By Disposable: Pre-filled Disposable Lancets, Single-use Lancets _x000D_
_x000D_
#Lancing Devices And Equipment Market Transformation Trends: What Innovations Are Driving Change?#_x000D_
Leading companies operating in the lancing devices and equipment market are engaged in developing innovative products, such as disposable lancing devices, to ensure a more convenient and comfortable experience for blood sugar monitoring. A disposable lancing device is a compact, portable instrument designed to prick the skin and collect a small blood sample for glucose testing. For instance, in August 2023, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, introduced Accu-Chek Pico. This fully disposable lancing device aims to simplify and enhance the convenience of blood sugar monitoring for individuals with diabetes, especially older adults. It offers numerous benefits for people with diabetes, particularly older adults. Its attributes include ease of use, gentleness on the skin, consistent lancing depths, and complete disposability. Additionally, it is compatible with a range of Accu-Chek blood glucose meters, which further assists people with diabetes._x000D_
_x000D_
#Lancing Devices And Equipment Market Top Companies Driving Competitive Growth#_x000D_
Major companies operating in the lancing devices and equipment market are Abbott laboratories, B. Braun Melsungen AG, Terumo Corporation, F. Hoffmann-La Roche AG, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Becton Dickinson and Company, Bayer AG, Medtronic plc, ARKRAY Inc., Sanofi S.A., Ypsomed Holding AG, Sarstedt AG & Co., Greiner Bio-One, HTL-STREFA S.A, Guangzhou Improve Medical Instruments Co. Ltd., UltiMed Inc., Allison Medical Inc., Artsana S.p.a., Perrigo Diabetes Care, MedExel Co. Ltd., Simple Diagnostics, Stat Medical Inc., Trividia Health, Eli Lilly and Company, Roche Diagnostics, Terumo Corporation, LifeScan, Dynarex Corporation, Dealmed Medical Supplies LLC, Advanced Diabetic Solutions, Medline Industries Inc., Owen Mumford, ARKRAY USA Inc., Nipro Diagnostics Inc., AgaMatrix Inc., Nova Biomedical, Prodigy Diabetes Care LLC, ACON Laboratories Inc. _x000D_
_x000D_
#View The Full Lancing Devices And Equipment Market Report:#_x000D_
_x000D_
#Lancing Devices And Equipment Market Global Footprint: Which Region Leads The Industry?#_x000D_
North America was the largest region in the global lancing devices and equipment market in 2025. Western Europe was the second-largest region in the lancing devices and equipment market. The regions covered in the lancing devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model